Company
Australian biotech firm specialising in peripheral nerve injury repair
Every investor coverage indicates participated in a round ReNerve raised.
Investors whose own portfolio pages list ReNerve, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Starfish Ventures | its portfolio page ↗ |
Companies ReNerve acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming ReNerve. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian biotech ReNerve and RMIT received a government grant of nearly AUD500,000 for a joint project aiming to speed nerve repair after prostate operations, under a federal program.